BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37118722)

  • 1. Role of skip N2 lymph node metastasis for patients with the stage III-N2 lung adenocarcinoma: a propensity score matching analysis.
    Wang S; Xie S; Han Y; Gao M; Su X; Liu Q
    BMC Pulm Med; 2023 Apr; 23(1):147. PubMed ID: 37118722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer.
    Jin J; Xu Y; Hu X; Chen M; Fang M; Hang Q; Chen M
    Curr Oncol; 2020 Jun; 27(3):e283-e293. PubMed ID: 32669935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Skip Mediastinal Lymph Node Metastasis for Patients With Resectable Non-small-cell Lung Cancer: A Propensity Score Matching Analysis.
    Wang L; Zhan C; Gu J; Xi J; Lin Z; Xue L; Ge D; Wang Q
    Clin Lung Cancer; 2019 May; 20(3):e346-e355. PubMed ID: 30665872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: the crucial role of histological type, number of resected nodes and adjuvant therapy.
    Chiappetta M; Lococo F; Leuzzi G; Sperduti I; Petracca-Ciavarella L; Bria E; Mucilli F; Filosso PL; Ratto GB; Spaggiari L; Facciolo F; Margaritora S
    Eur J Cardiothorac Surg; 2020 Dec; 58(6):1236-1244. PubMed ID: 32770184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of nodal classification for non-small cell lung cancer by merging current N categories with the number of involved lymph node stations.
    Chen W; Zhang C; Wang G; Yu Z; Liu H
    Thorac Cancer; 2019 Jul; 10(7):1533-1543. PubMed ID: 31207184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients.
    Li X; Li X; Fu X; Liu L; Liu Y; Zhao H; Li Y; Hu J; Xu L; Liu D; Yang H; Zhang X
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1874-1881. PubMed ID: 31902592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of the number of lymph nodes removed on the accuracy of a newly proposed N descriptor classification in patients with surgically-treated lung cancer.
    Dziedzic DA; Cackowski MM; Zbytniewski M; Gryszko GM; Woźnica K; Orłowski TM;
    Surg Oncol; 2021 Jun; 37():101514. PubMed ID: 33429325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung adenocarcinoma: Are skip N2 metastases different from non-skip?
    Li H; Hu H; Wang R; Li Y; Shen L; Sun Y; Chen H
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):790-5. PubMed ID: 26282606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New N1/N2 classification and lobe specific lymphatic drainage: Impact on survival in patients with non-small cell lung cancer treated with surgery.
    Tsitsias T; Okiror L; Veres L; King J; Harrison-Phipps K; Routledge T; Pilling J; Bille A
    Lung Cancer; 2021 Jan; 151():84-90. PubMed ID: 33250210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic score for survival with pulmonary carcinoids: the importance of associating clinical with pathological characteristics.
    Chiappetta M; Sperduti I; Ciavarella LP; Leuzzi G; Bria E; Mucilli F; Lococo F; Filosso P; Ratto G; Spaggiari L; Facciolo F; Margaritora S
    Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):315-323. PubMed ID: 32747930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases.
    Qiao R; Zhong R; Xu J; Zhang Y; Zhang B; Wang S; Lou Y; Chen D; Chang Q; Zhao Y; Han B
    J Cardiothorac Surg; 2019 Mar; 14(1):63. PubMed ID: 30925891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skip N2 Metastasis in Pulmonary Adenocarcinoma: Good Prognosis Similar to N1 Disease.
    Wang L; Ye G; Xue L; Zhan C; Gu J; Xi J; Lin Z; Jiang W; Ge D; Wang Q
    Clin Lung Cancer; 2020 Sep; 21(5):e423-e434. PubMed ID: 32245623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between Lymph Node Ratio and Clinicopathological Features and Prognosis of IIIa-N2 Non-small Cell Lung Cancer].
    Zhang S; Wang L; Lu F; Pei Y; Yang Y
    Zhongguo Fei Ai Za Zhi; 2019 Nov; 22(11):702-708. PubMed ID: 31771739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Review for N2 Sub-staging in Non-small Cell Lung Cancer].
    Bao Y; Hui Z
    Zhongguo Fei Ai Za Zhi; 2022 Dec; 25(12):870-876. PubMed ID: 36617473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.
    Asamura H; Chansky K; Crowley J; Goldstraw P; Rusch VW; Vansteenkiste JF; Watanabe H; Wu YL; Zielinski M; Ball D; Rami-Porta R;
    J Thorac Oncol; 2015 Dec; 10(12):1675-84. PubMed ID: 26709477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Station 3A lymph node dissection does not improve long-term survival in right-side operable non-small-cell lung cancer patients: A propensity score matching study.
    Yang MZ; Tan ZH; Li JB; Long H; Fu JH; Zhang LJ; Lin P; Hou X; Yang HX
    Thorac Cancer; 2022 Aug; 13(15):2106-2116. PubMed ID: 35702992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas.
    Guerrera F; Renaud S; Tabbó F; Voegeli' AC; Filosso PL; Legrain M; Boita M; Schaeffer M; Beau-Faller M; Ruffini E; Falcoz PE; Inghirami G; Oliaro A; Massard G
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):680-688. PubMed ID: 28329143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].
    Liu K; Chen HL; You QS; Huang JF; Wang H
    Ai Zheng; 2009 Jul; 28(7):725-9. PubMed ID: 19624899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.